Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

I Kislaya, EF Rodrigues, V Borges, JP Gomes, C Sousa… - MedRxiv, 2021 - medrxiv.org
Abstract Background The SARS-CoV-2 Delta variant (B. 1.617. 2), initially identified in India,
has become predominant in several countries, including Portugal. Few studies have …
被引用次数：12 相关文章
[PDF] archive.org

[PDF][PDF] Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

I Kislaya, EF Rodrigues, V Borges, JP Gomes, C Sousa… - scholar.archive.org
Abstract Background: The SARS-CoV-2 Delta variant (B. 1.617. 2), initially identified in India,
has become predominant in several countries, including Portugal. Few studies have …
[HTML] europepmc.org

[HTML][HTML] Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

I Kislaya, EF Rodrigues, V Borges, JP Gomes, C Sousa… - 2021 - europepmc.org
Background The SARS-CoV-2 Delta variant (B. 1.617. 2), initially identified in India, has
become predominant in several countries, including Portugal. Few studies have compared …

Delta variant and mRNA COVID-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

I Kislaya, E Freire Rodrigues, V Borges… - … on Applied Infectious …, 2021 - repositorio.insa.pt
Information on COVID-19 vaccines' effectiveness and viral loads in vaccine infection
breakthrough cases are critical to inform decision-makers. Few studies have compared the …